MERCK KGAA O.N. (MRK.DE) Financials
MRK.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 49.9 billion | 21.6 billion |
| 2023-06-30 | 48.8 billion | 22.0 billion |
| 2023-03-31 | 48.6 billion | 22.4 billion |
| 2022-12-31 | 48.5 billion | 22.5 billion |
MRK.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | 793.0 million | ? |
| 2023-06-30 | 295.0 million | ? |
| 2023-03-31 | 202.0 million | ? |
| 2022-12-31 | 483.0 million | -7.0 million |
MRK.DE Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | 740.0 million |
| 2023-06-30 | 706.0 million |
| 2023-03-31 | 800.0 million |
| 2022-12-31 | 659.0 million |
MRK.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 2.6 billion | - | - |
| 2023-06-30 | 1.9 billion | - | - |
| 2023-03-31 | 1.7 billion | - | - |
| 2022-12-31 | 1.6 billion | - | 491.0 million |
MRK.DE Shares Outstanding
MRK.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 462.0 million | 581.0 million | 312.0 million | 1.1 billion |
| 2023-06-30 | 327.0 million | 600.0 million | 345.0 million | 1.1 billion |
| 2023-03-31 | 651.0 million | 597.0 million | 358.0 million | 1.1 billion |
| 2022-12-31 | 532.0 million | 694.0 million | 360.0 million | 593.0 million |
MRK.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 5.2 billion | 2.2 billion |
| 2023-06-30 | 5.3 billion | 2.1 billion |
| 2023-03-31 | 5.3 billion | 2.0 billion |
| 2022-12-31 | 5.7 billion | 2.3 billion |
MRK.DE
Price: €150
Dividend Yield: 0.01%
Forward Dividend Yield: 1.45%
Payout Ratio: 33.03%
Dividend Per Share: 2.20 EUR
Earnings Per Share: 6.49 EUR
P/E Ratio: 22.65
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 187965
Market Capitalization: 66.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 24
DGR3: 1.64%
DGR5: 22.58%
DGR10: 15.34%